Latest Schedule 13G passive stakes

CIBC Global Asset Management Inc. has updated its beneficial ownership filing for North American Construction Group Ltd., reporting a 4.84% stake as of June 30, 2026.

Farallon Capital Management, L.L.C. and its affiliates have reported beneficial ownership of 5.5% of BridgeBio Pharma, Inc.'s common stock as of June 30, 2026.

Farallon Capital Management, L.L.C. and its affiliates have reported beneficial ownership of 5,917,400 shares, representing 9.9% of the outstanding common stock of Agios Pharmaceuticals, Inc.

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 8.5% of Crinetics Pharmaceuticals, Inc. common stock as of June 30, 2026.

Filings reveal significant beneficial ownership stakes in StepStone Group Inc. by Integrated Core Strategies, Millennium Management, and Israel A. Englander.

Several entities, including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, have jointly filed a Schedule 13G regarding their beneficial ownership of Voyager Therapeutics, Inc. common stock.

Vladimir Galkin, Angelica Galkin, and the Angelica Galkin Revocable Trust have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 6.1% in One Stop Systems, Inc.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported a 3.6% stake in Churchill Capital Corp XI's Class A Ordinary Shares.

JW Asset Management, along with affiliated entities, has reported beneficial ownership of 9.15% of Establishment Labs Holdings, Inc. common stock as of June 30, 2026.

F. Laeisz GmbH, KG Reederei N. Schues mbH + Co., and Nikolaus H. Schues have filed a Schedule 13G amendment, indicating they no longer beneficially own more than 5% of Diana Shipping Inc. common stock.

UBS Group AG has filed a Schedule 13G, reporting no beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30, 2026.

UBS Group AG has filed a Schedule 13G, reporting no beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30, 2026.

RA Capital Management, along with affiliated entities and individuals, has reported beneficial ownership of 9.9% of Inhibikase Therapeutics' common stock.

Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have jointly filed a Schedule 13G, reporting beneficial ownership of 1,325,482 shares of C3is Inc. common stock, representing 9.99% of the class.

UBS Group AG has filed an amendment to its Schedule 13G, correcting the event date for its previous filing concerning AMC Entertainment Holdings, Inc. Class A common stock.

UBS Group AG has filed an amendment to its Schedule 13G, correcting the event date for its previous filing concerning AMC Entertainment Holdings, Inc. Class A common stock.

Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, disclosing beneficial ownership of 2,400,000 shares of Harrow, Inc. common stock, representing 6.44% of the outstanding shares.

Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, reporting beneficial ownership of 309,948 shares of SANUWAVE Health, Inc. common stock, representing 3.6% of the outstanding shares.

Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, disclosing a beneficial ownership of 5.49% in Q32 Bio Inc.

Opaleye Management Inc., Opaleye L.P., and James Silverman have jointly filed a Schedule 13G, reporting beneficial ownership of 2,050,000 shares of Pasithea Therapeutics Corp. common stock, representing 6.14% of the outstanding shares.

Octagon Capital Advisors LP, along with affiliated entities and its principal beneficial owner Ting Jia, has reported beneficial ownership of 3.3% of Context Therapeutics Inc. common stock.

UBS Group AG has filed an amended Schedule 13G, reporting 0% beneficial ownership of AMC Entertainment Holdings, Inc. Class A common stock as of December 31, 2025.

UBS Group AG has filed an amended Schedule 13G, reporting 0% beneficial ownership of AMC Entertainment Holdings, Inc. Class A common stock as of December 31, 2025.

Vanguard Capital Management and Vanguard Total Stock Market Index Fund have reported a combined beneficial ownership of 9.82% in FG Nexus Inc. as of June 30, 2026.

Allspring Global Investments Holdings, LLC has disclosed a 3.1% stake in Voya Emerging Markets High Dividend Mutual Fund.

Allspring Global Investments Holdings, LLC has filed a Schedule 13G, reporting no beneficial ownership of Mutual Fund SH CL B securities in the Total Return Securities Fund.

Allspring Global Investments Holdings, LLC has increased its beneficial ownership in The New Germany Fund Inc. to 10.4%, holding 1,697,984 shares.

Allspring Global Investments Holdings, LLC has increased its beneficial ownership of Myers Industries Inc. common stock to 3.7%, holding 1,400,451 shares.

Allspring Global Investments Holdings, LLC has reported an increase in its beneficial ownership of The Mexico Fund, Inc. to 5.9%.

Allspring Global Investments Holdings, LLC has reported a beneficial ownership of 15.8% in the Japan Smaller Capitalization Mutual Fund.